Product Images Deferasirox

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Deferasirox NDC 69097-560 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image - ce7e02d0 319e 4a5b 87e1 c6550ab4322c 01

Image - ce7e02d0 319e 4a5b 87e1 c6550ab4322c 01

Image - ce7e02d0 319e 4a5b 87e1 c6550ab4322c 02

Image - ce7e02d0 319e 4a5b 87e1 c6550ab4322c 02

90 mg - ce7e02d0 319e 4a5b 87e1 c6550ab4322c 03

90 mg - ce7e02d0 319e 4a5b 87e1 c6550ab4322c 03

This is a medication called Deferasirox Oral Granules, manufactured by Cipla. Each sachet contains 162 mg granule that is equivalent to 90 mg deferasirox. The medication guide is to be dispensed with it, and it is recommended to take the dosage as instructed by the doctor. The package is child-resistant, and it should be stored between 20°C to 25°C (68°F to 77°F). The lot number provided will be overprinted during commercial packing, and it contains 30 sachets. The patient should carefully open the sachet and pour the entire contents onto soft food like yogurt or apple sauce. The dose should be immediately consumed, and no granules should remain in the sachet.*

180 mg - ce7e02d0 319e 4a5b 87e1 c6550ab4322c 04

180 mg - ce7e02d0 319e 4a5b 87e1 c6550ab4322c 04

Deferasirox is an oral medication in the form of granules sold by Cipla. Each sachet contains 324 mg granule equivalent to 180 mg deferasirox, and the box contains 30 sachets. The patient must shake the sachet gently to settle the contents and tear it open along the cut line or use scissors to cut across it. The entire contents of the sachet must be poured on soft food such as yogurt or apple sauce. The dose must be consumed immediately, and not stored for future use. The medication must be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Each sachet must not be stored for more than a single use, and the package is child-resistant. The manufacturer of the medication is Cipla Ltd, Kurkumbh, India, and is manufactured for Cipla USA Inc.*

360 mg - ce7e02d0 319e 4a5b 87e1 c6550ab4322c 05

360 mg - ce7e02d0 319e 4a5b 87e1 c6550ab4322c 05

Deferasirox is an oral granule medication packaged in sachets manufactured by Cipla. Each sachet contains 648 mg granule equivalent to 360 mg deferasirox, and the medication guide must be dispensed with each pack. The patient should shake the sachet and tear it open along the cut line to carefully pour the entire contents on soft food before consumption. Deferasirox should be stored at 20°C to 25°C and protected from moisture. The package is child-resistant and comes in a batch with a serial number, lot number, and expiry date printed during commercial packing. The text includes instructions for the pharmacist and prescribing information.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.